Fat cell injections aim to slow aggressive MS in first human test
NCT ID NCT06592703
First seen Jan 11, 2026 · Last updated May 06, 2026 · Updated 16 times
Summary
This early-stage study tests whether repeated injections of stem cells from donated fat tissue are safe for people with primary progressive multiple sclerosis (MS), a form that steadily worsens. Ten adults aged 18–55 with moderate disability will receive the cells directly into the spine. The main goal is to check for serious side effects; researchers will also watch for any signs of slowed disease progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
APHP Henri Mondor
ACTIVE_NOT_RECRUITINGCréteil, France
-
CHU Rennes
RECRUITINGRennes, France
Contact
Contact
Conditions
Explore the condition pages connected to this study.